Private Ocean’s Myovant Sciences Ltd. MYOV Stock Holding History

Private Ocean’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-700	Closed	-$9K	–	540
2017 Q4	$9K	Buy	+700	New	+$9.39K	0.01%	245

Other funds holding MYOV

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Private Ocean's MYOV Position: Q1 2018 in Review

Private Ocean sold out of Myovant Sciences Ltd. (MYOV) in Q1 2018, closing a stake of 700 shares — an estimated $9K sold.

Private Ocean first reported a position in MYOV in Q4 2017 and held it in 1 quarter. The position peaked at $9K in Q4 2017. 32 funds tracked by Wall St. Rank hold MYOV as of Q1 2018.

Private Ocean reported no remaining Myovant Sciences Ltd. position as of Q1 2018 after selling out during the quarter.
Private Ocean sold 700 Myovant Sciences Ltd. shares in Q1 2018, an estimated $9K.
Private Ocean first reported a position in Myovant Sciences Ltd. in Q4 2017 and held it in 1 quarter.
Private Ocean's Myovant Sciences Ltd. position peaked at $9K in Q4 2017.
32 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2018.

Based on Private Ocean's 13F filing for Q1 2018, filed 11 May 2018.